Cubist Systematic Strategies’s Tenaya Therapeutics TNYA Stock Holding History

Cubist Systematic Strategies’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$6.67K	Sell	4,115 -191,983	-98%	-$193K	﹤0.01%	2935
2025 Q2	$120K	Buy	+196,098	New	+$99.8K	﹤0.01%	2687
2024 Q4	–	Sell	-49,094	Closed	-$94.8K	–	3565
2024 Q3	$94.8K	Buy	+49,094	New	+$139K	﹤0.01%	2698
2023 Q1	–	Sell	-20,261	Closed	-$40.7K	–	4424
2022 Q4	$40.7K	Sell	20,261 -3,581	-15%	-$8.74K	﹤0.01%	3931
2022 Q3	$69K	Buy	+23,842	New	+$111K	﹤0.01%	4079

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Cubist Systematic Strategies's TNYA Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Tenaya Therapeutics (TNYA) stake by 98% in Q3 2025, selling an estimated $193K and leaving 4,115 shares worth $6.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2935.

Cubist Systematic Strategies first reported a position in TNYA in Q3 2022 and has held it in 5 quarters since. The position peaked at $120K in Q2 2025. 91 funds tracked by Wall St. Rank hold TNYA as of Q3 2025.

Cubist Systematic Strategies held 4,115 shares of Tenaya Therapeutics worth $6.67K as of Q3 2025.
Cubist Systematic Strategies sold 191,983 Tenaya Therapeutics shares in Q3 2025, an estimated $193K.
Tenaya Therapeutics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2935 holding.
Cubist Systematic Strategies first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 5 quarters since.
Cubist Systematic Strategies's Tenaya Therapeutics position peaked at $120K in Q2 2025.
91 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.